Bayer To Present Phase III Xarelto Results On Nov 13
Fox Business Friday 7th October, 2011
Dow Jones )- German chemical and pharmaceutical company Bayer AG (BAYN.XE) said Friday that Phase III test results of its blood-thinner drug Xarelto will be presented at the American Heart Association's scientific sessions on Nov. 13. MAIN FACTS: -The results will be presented by Michael Gibson at the late breaking clinical trials session in Boston...





Comments
No comments yet for this story